Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

2.6K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
2.6K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

1.1K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

622
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
622
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fibroblastic aspartoacylase suppresses TGFβ-mediated responses and cancer progression.

Nature communications·2026
Same author

Bcl-xL blockade targets neutrophils and synergizes with chemotherapy in lung squamous cell carcinoma.

EMBO molecular medicine·2026
Same author

Mitochondrial IκBα fuels cancer progression through metabolic rewiring, endothelial activation, and thrombotic spread.

Cell death discovery·2026
Same author

Transcriptome changes in circulating immune cells of critical COVID-19 patients predict a specific metabolic and epigenetic imprint.

Journal of translational medicine·2026
Same author

Murine vascular organoids are responsive and adaptable 3D systems with cellular heterogeneity and dynamic plasticity.

Science advances·2025
Same author

IFNγ-Induced PD-L1+MHCII+ Macrophages and Tim-3+ Tumor-Reactive CD8+ T Cells Predict a Response to Anti-PD-1 Therapy in Tumor-Bearing Mice.

Cancer immunology research·2025

Related Experiment Video

Updated: Aug 15, 2025

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

9.1K

PHD2 Constrains Antitumor CD8+ T-cell Activity.

Charlotte Bisilliat Donnet1,2, Valérie Acolty1,2, Abdulkader Azouz2,3

  • 1Laboratory of Immunobiology, Université Libre de Bruxelles, Gosselies, Belgium.

Cancer Immunology Research
|January 5, 2023
PubMed
Summary
This summary is machine-generated.

Targeting the PHD2/HIF-1 pathway in T cells boosts antitumor immunity. Deleting PHD2 enhances CD8+ T cell function and tumor regression, offering a promising strategy for cancer immunotherapy.

More Related Videos

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

12.8K
Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
12:08

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Published on: May 17, 2019

9.3K

Related Experiment Videos

Last Updated: Aug 15, 2025

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

9.1K
Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

12.8K
Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
12:08

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Published on: May 17, 2019

9.3K

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • The prolyl hydroxylase domain/hypoxia-inducible factor (PHD/HIF) pathway regulates cellular responses to oxygen levels.
  • This pathway is crucial in the tumor microenvironment and influences immune cell function.
  • HIF stabilization has been linked to various immune and inflammatory processes.

Purpose of the Study:

  • To investigate the impact of stabilizing the PHD/HIF pathway on antitumor immunity.
  • To determine if selective deletion of Phd2 in T lymphocytes enhances anti-cancer immune responses.

Main Methods:

  • Utilized the cre/lox system for selective deletion of Phd2 in T lymphocytes.
  • Assessed tumor regression in EG7-OVA tumor models.
  • Analyzed CD8+ tumor-infiltrating lymphocytes for polyfunctionality (IFNγ, TNFα, granzyme B expression).
  • Performed phenotypic and transcriptomic analyses.

Main Results:

  • Selective deletion of PHD2 in T lymphocytes led to enhanced regression of EG7-OVA tumors.
  • Tumor control was dependent on HIF-1α.
  • Enhanced CD8+ T cell polyfunctionality, including increased IFNγ, TNFα, and granzyme B production, was observed.
  • Glycolysis was identified as critical for sustaining CD8+ T cell activity in the tumor microenvironment.

Conclusions:

  • PHD2 deletion in T lymphocytes enhances antitumor immunity through HIF-1α stabilization.
  • The PHD2/HIF-1 pathway is a critical regulator of CD8+ T cell function in tumors.
  • Targeting the PHD2/HIF-1 pathway represents a potential therapeutic strategy for cancer immunotherapy.